Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PAVmed (PAVM) FCF Margin (2022 - 2025)

Historic FCF Margin for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to 18060.0%.

  • PAVmed's FCF Margin changed N/A to 18060.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 12665.52%, marking a year-over-year change of. This contributed to the annual value of 1123.71% for FY2024, which is 10083500.0% up from last year.
  • According to the latest figures from Q3 2025, PAVmed's FCF Margin is 18060.0%.
  • In the past 5 years, PAVmed's FCF Margin ranged from a high of 440.0% in Q4 2024 and a low of 25864.47% during Q3 2022
  • Over the past 4 years, PAVmed's median FCF Margin value was 6792.06% (recorded in 2022), while the average stood at 9396.82%.
  • Its FCF Margin has fluctuated over the past 5 years, first surged by 244603000bps in 2023, then tumbled by -189424200bps in 2025.
  • Quarter analysis of 4 years shows PAVmed's FCF Margin stood at 15286.61% in 2022, then skyrocketed by 92bps to 1149.38% in 2023, then surged by 138bps to 440.0% in 2024, then tumbled by -4205bps to 18060.0% in 2025.
  • Its last three reported values are 18060.0% in Q3 2025, 20133.33% for Q2 2025, and 20075.0% during Q1 2025.